Eligibility Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module

Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2025-12-24 @ 9:58 PM
NCT ID: NCT05472532
Eligibility Criteria: * Inclusion Criteria for all cohorts \* : * Age \> 18 * Signed consent * Inclusion criteria for the "Prostate" cohort: * prostate adenocarcinoma histologically proven * metastatic situation * at least 2 metastatic sites * Evolutionary disease that requires a new treatment * Inclusion criteria for the "Breast" cohort: * HER2+ or RH+ breast adenocarcinoma histologically proven * metastatic situation * at least 2 metastatic sites * Evolutionary disease that requires a new treatment * Inclusion criteria for the "Lung" cohort: * Non Small Lung cancer histologically proven * metastatic situation * at least 2 metastatic sites * Evolutionary disease that requires a new treatment * Inclusion criteria for "Ovarian" cohort: * Ovarian cancer histologically proven * Presence of peritoneal carcinomatosis (stage IIIC or IV); with or without presence of peritoneal fluid * Inclusion criteria for "Colo-Rectal" cohort: * Colo-rectal cancer histologically proven * Presence of peritoneal carcinomatosis, with or without presence of peritoneal fluid * Evolutionary disease that requires a new treatment * Inclusion criteria for "Gastric" cohort: * Gastric cancer histologically proven * Presence of peritoneal carcinomatosis, with or without presence of peritoneal fluid * Exclusion Criteria for all cohorts \* : * Weight \<50kg * Parallel participation in a doubled blinded study * Brain or ganglionary metastasis only
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT05472532
Study Brief:
Protocol Section: NCT05472532